United States · 
Who invested in SURGE Therapeutics?
SURGE Therapeutics's investors include Alumni Ventures, Khosla Ventures, 8VC, KdT Ventures and Pitango VC.
United States · Series B startup
Who invested in SURGE Therapeutics
Funding summaryUpdated 26 Oct 2026
$32Mraised across 1 round since 2023, from 1 source
- Latest round
- Series B, $32MJul 2023
- Investors
- 5
The rounds
- Jul 2023Series B$32M
Source recordedSEC filing: $32M sold, first sale May 2023
Founders and team
From SURGE Therapeutics's own website and the SEC filings it signed: 5 on the team.
- Chuck S. CarignanCEO
- Michael S. GoldbergCEO
- Kayti AvianoVP, Clinical Operations
- Paul KonowiczHead of Formulations
- Antonio S. GualbertoExecutive Officeri
On the board, as filediAli S. FarahanchiGary S. GoldbergJason S. ColomaKouki S. Harasaki
AdvisersFrancis Cuss
Everyone who backed them
Pitango VCno record of our own yet1round
Missing a round, or an investor who was in one? Tell us.
Quick answers about SURGE Therapeutics
How much has SURGE Therapeutics raised?
SURGE Therapeutics has raised $32M across 1 round since 2023.
When did SURGE Therapeutics last raise?
SURGE Therapeutics's most recent round was a Series B of $32M in Jul 2023.
What was SURGE Therapeutics's biggest round?
Its most recent round, $32M in Jul 2023, is also its largest on record.
Who backed SURGE Therapeutics first?
SURGE Therapeutics's first round on record, in Jul 2023, was backed by Alumni Ventures, Khosla Ventures and 8VC and 2 others.
What stage is SURGE Therapeutics at?
SURGE Therapeutics's latest named round is a Series B, in Jul 2023.
Where is SURGE Therapeutics based?
SURGE Therapeutics is based in the United States.
Companies like SURGE Therapeutics
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.